Recruitment of racial and ethnic minorities to clinical trials conducted within specialty clinics: an intervention mapping approach

被引:41
|
作者
Amorrortu, Rossybelle P. [1 ]
Arevalo, Mariana [2 ]
Vernon, Sally W. [2 ]
Mainous, Arch G., III [3 ]
Diaz, Vanessa [4 ]
McKee, M. Diane [5 ]
Ford, Marvella E. [6 ,7 ]
Tilley, Barbara C. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston UT Hlth, Sch Publ Hlth, Dept Biostat & Data Sci, 1200 Hermann Pressler, Houston, TX 77030 USA
[2] Univ Texas Hlth Sci Ctr Houston UT Hlth, Dept Hlth Promot & Behav Sci, Sch Publ Hlth, 1200 Hermann Pressler, Houston, TX 77030 USA
[3] Univ Florida, Dept Hlth Serv Res Management & Policy, Hlth Sci Ctr, Coll Publ Hlth & Hlth Profess, POB 100195, Gainesville, FL 32610 USA
[4] Med Univ South Carolina, Dept Family Med, 5 Charleston Ctr Dr,Suite 263, Charleston, SC 29425 USA
[5] Albert Einstein Coll Med, Dept Family & Social Med, 1300 Morris Pk Ave Block,Room 417, Bronx, NY 10467 USA
[6] Med Univ South Carolina, Dept Publ Hlth Sci, 68 President St,Suite BE103, Charleston, SC 29425 USA
[7] Med Univ South Carolina, Hollings Canc Ctr, 68 President St,Suite BE103, Charleston, SC 29425 USA
关键词
Program development; Trust; Relationship building; Social cognitive theory; Specialist; Training; UNDERREPRESENTED POPULATIONS; AFRICAN-AMERICAN; PARTICIPATION; CANCER; BARRIERS; FACILITATORS; PHYSICIAN; DISEASE; PATIENT; STRATEGIES;
D O I
10.1186/s13063-018-2507-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Despite efforts to increase diversity in clinical trials, racial/ethnic minority groups generally remain underrepresented, limiting researchers' ability to test the efficacy and safety of new interventions across diverse populations. We describe the use of a systematic framework, intervention mapping (IM), to develop an intervention to modify recruitment behaviors of coordinators and specialist investigators with the goal of increasing diversity in trials conducted within specialty clinics. To our knowledge IM has not been used in this setting. Methods: The IM framework was used to ensure that the intervention components were guided by health behavior theories and the evidence. The IM steps consisted of (1) conducting a needs assessment, (2) identification of determinants and objectives, (3) selection of theory-informed methods and practical applications, (4) development and creation of program components, (5) development of an adoption and implementation plan, and (6) creation of an evaluation plan. Results: The intervention included five educational modules, one in-person and four web-based, plus technical assistance calls to coordinators. Modules addressed the intervention rationale, development of clinic-specific plans to obtain minority-serving physician referrals, physician-centered and patient-centered communication, and patient navigation. The evaluation, a randomized trial, was recently completed in 50 specialty clinics and is under analysis. Conclusions: Using IM we developed a recruitment intervention that focused on building relationships with minorityserving physicians to encourage minority patient referrals. IM enhanced our understanding of factors that may influence minority recruitment and helped us integrate strategies from multiple disciplines that were relevant for our audience.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Recruitment of racial and ethnic minorities to clinical trials conducted within specialty clinics: an intervention mapping approach
    Rossybelle P. Amorrortu
    Mariana Arevalo
    Sally W. Vernon
    Arch G. Mainous
    Vanessa Diaz
    M. Diane McKee
    Marvella E. Ford
    Barbara C. Tilley
    Trials, 19
  • [2] Underrepresentation of Racial and Ethnic Minorities in Stroke Clinical Trials
    Izeogu, Chigozirim
    Bhojwani, Manish
    Ahmed, Mariam
    Chang, Kelly
    Mehta, Amol
    Ibrahim, Lamya
    Rocha, Eva
    Jones, Erica
    Ifejika, Nneka L.
    Gonzales, Nicole R.
    Sharrief, Anjail Z.
    STROKE, 2024, 55
  • [3] Underrepresentation Of Racial And Ethnic Minorities In Stroke Clinical Trials
    Izeogu, Chigozirim
    Bhojwani, Manish
    Ahmed, Mariam
    Chang, Kelly
    Mehta, Amol
    Ibrahim, Lamya
    Rocha, Eva
    Jones, Erica
    Fejika, Nneka L.
    Gonzales, Nicole R.
    Sharrief, Anjail Z.
    STROKE, 2024, 55
  • [4] Impact of Clinical Trial Design on Recruitment of Racial and Ethnic Minorities
    Sheikh, Saad
    Bruno, Debora S.
    Sun, Yilun
    Deng, Victoria
    Mcclelland, Shearwood
    Obi, Elizabeth
    Vinson, Valerie
    Firstencel, April
    Lanese, Bob
    Lausin, Loretta
    Dorth, Jennifer A.
    Zaorsky, Nicholas G.
    Hoy, Kevin
    Krishnamurthi, Smitha
    JOURNAL OF CANCER EDUCATION, 2024, 39 (05) : 567 - 572
  • [5] Underrepresentation of racial and ethnic minorities in metastatic colorectal carcinoma clinical trials within the United States
    Pu, T.
    Gustafson, A.
    Ghabra, S.
    Luberice, K.
    Snyder, R.
    Blakely, A.
    Eng, O.
    ANNALS OF ONCOLOGY, 2023, 34 : S62 - S62
  • [6] REPRESENTATION OF GENDER, RACIAL, AND ETHNIC MINORITIES IN HEPATOLOGY CLINICAL TRIALS
    Li, Kin
    Bouso, Muhammed
    Mushannen, Malik
    Pellergrino, Carla
    Harroch, Joshua
    Karim, Gres
    Brown, Nicholas
    Weisberg, Ilan
    HEPATOLOGY, 2024, 80 : S2008 - S2009
  • [7] Underrepresentation of Ethnic and Racial Minorities in Atrial Fibrillation Clinical Trials
    Nunes, Julio C.
    Rice, Eli N.
    Stafford, Randall S.
    Lewis, Eldrin F.
    Wang, Paul J.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2021, 14 (12): : 1094 - 1095
  • [8] REPRESENTATION OF RACIAL AND ETHNIC MINORITIES IN ATRIAL FIBRILLATION CLINICAL TRIALS
    Lan, Roy
    Paranjpe, Ishan
    Perez, Marco
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 19 - 19
  • [9] Recruitment and Retention Strategies Among Racial and Ethnic Minorities in Web-Based Intervention Trials: Retrospective Qualitative Analysis
    Hwang, DaSol Amy
    Lee, Alex
    Song, Jae Min
    Han, Hae-Ra
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2021, 23 (07)
  • [10] An evaluation of prescreen recruitment data: enrolling racial/ethnic minorities in Phase I HIV vaccine clinical trials
    Johnson, D.
    Merino, Y.
    Berkowitz, N.
    Vasilenko, O.
    Larkin, B.
    Young, S.
    Graham, B.
    Ledgerwood, J. M.
    RETROVIROLOGY, 2009, 6